Omalizumab Therapy for Chronic Hives

Omalizumab is an injectable medicine that can help control chronic spontaneous hives when standard treatment is insufficient.

Hives are raised, itchy welts that can come and go; some people also develop deeper swelling called angioedema. Omalizumab works on an immune pathway involving IgE. It is prescribed after a clinician has confirmed the pattern and considered other causes of recurrent rash or swelling.

Omalizumab is given as an injection under the skin. There may be a brief pinch, pressure or stinging at the injection site. Temporary redness, swelling, bruising or soreness can occur afterwards.

Tell the nurse if injections have been difficult for you in the past or if you feel faint around needles. The team can help with positioning and can check the injection area before you leave.

Omalizumab is used under medical supervision, with the prescribing clinician checking whether it suits your medical history and current medicines. Injection-site reactions, headache and fatigue can occur. Your clinician will explain the effects that matter most for you.

A serious allergic reaction is uncommon but needs urgent care. Get emergency help for breathing difficulty, throat tightness, faintness, widespread hives with sudden illness, or swelling of the lips, tongue or face after an injection. Do not assume that every flare is caused by the medicine.

Response timing differs between people. The treatment is given on a schedule determined by the prescriber, and symptom control is reviewed over time using your experience of wheals, itch, swelling and sleep disruption.

Benefit generally depends on continuing the agreed treatment plan. If treatment is paused, hives may return; this reflects the underlying condition remaining active rather than a failure on your part. The prescriber will decide whether to continue, adjust or stop treatment based on your response.

Keep a record of hive flares, swelling episodes, triggers you suspect, medicines used for relief and any reactions after injections. That record helps distinguish breakthrough disease activity from a possible treatment reaction and gives the clinician a clearer basis for follow-up decisions.

Omalizumab may be considered for chronic spontaneous hives that remain disruptive despite standard non-sedating antihistamine treatment. Chronic hives can present with itch and recurring wheals, but other rashes and swelling conditions need their own assessment before this treatment is chosen.

Tell the prescriber about prior allergic reactions, pregnancy or plans for pregnancy, asthma or other medical conditions, and all medicines you take. This helps shape monitoring and ensures there is a plan for symptoms that need urgent assessment.

The clinic confirms your current health, reviews recent reactions and prepares the prescribed injection. After the injection, you may be observed for a period set by the service, particularly when starting treatment or when your clinician considers it necessary.

Before leaving, make sure you know when the next dose is due, how to report a delayed reaction and which symptoms require emergency help. Do not change other hive medicines unless the prescriber has discussed that change with you.

Most people can return to usual activities after the visit unless they feel unwell or the clinic gives different instructions. Avoid rubbing the injection site. If soreness occurs, use the advice provided by the treatment team and report a reaction that is spreading, severe or persistent.

Call emergency services for trouble breathing, wheeze, throat or tongue swelling, collapse, or rapidly worsening symptoms after an injection. Seek prompt medical advice for fever with a severe rash, unusual bruising, or a concern that does not fit your usual hives pattern.

For chronic hives, care often begins with identifying the diagnosis and using non-sedating antihistamines as directed. The clinician may adjust that plan or consider other specialist treatments when symptoms remain uncontrolled. Avoid stopping prescribed treatment suddenly without discussing it, especially if swelling has occurred.

A dermatologist or allergy specialist can assess recurrent hives, rule out other causes where appropriate and arrange a monitored treatment plan. Bring photographs of transient welts, as the skin can look normal by the time of the appointment.